Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Fig. 2

Distribution of Ki67 Distribution of A Ki67Baseline for all patients, B Ki672week in patients allocated control, C percentage change Ki67 in patients allocated control, D Ki672week in patients allocated AI and E Percentage change Ki67 in patients allocated AI. Presented separately for HER2- and HER2 + patients

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us